BENCHMARK PROFILE
Medvinci Research
Latest sync: Oct 3, 2026, 9:44 AM. Source coverage currently reflects PB Evidence data.
Readers who want an openly priced research catalog with clear house-label mappings and a centralized, independently checked two-laboratory COA index.
Vendor-stated Houston, Texas fulfillment area and 346-area support line; no street-level public address verified. Public checkout code WELCOME15 is a vendor promotion, not a PeptideBenchmark affiliate offer. Research-use-only. Observed August 9, 2026.
GLP-3 RT / GLP-2 TZ are branded storefront labels for retatrutide / tirzepatide. 9 legacy PS* Freedom rows are labeled Previous supplier report and kept as provider-valid history outside current evidence; the 18 current Freedom reports use Medv* codes. Bundles, BAC supplies, and 10-vial kits stay outside the peptide comparison board.
A Houston-area research storefront with openly priced vial strengths, clear GLP house labels, and a public /coas/ index with 18 exact Freedom Diagnostics reports and 5 exact Kovera Labs records.
Medvinci Research sells research-only singles and blends with prices and size options on the public catalog, including house labels GLP-3 RT and GLP-2 TZ for retatrutide and tirzepatide. The current retrievable /coas/ set contains 18 Freedom Diagnostics documents and 5 Kovera Labs records; PeptideBenchmark confirms all 23 against the exact issuing-laboratory report.
The current /coas/ index yields 18 Freedom Diagnostics documents and 5 Kovera Labs records. PeptideBenchmark independently confirms the exact search code or report credential at the issuing laboratory and re-checks it on the normal trust cadence. A matched certificate documents the tested sample and does not endorse every vial.
This vendor is one of 130 names currently included in our manual curated research-vendor layer.
This is the strongest public transparency pattern on the site. The key signal is that readers can leave the vendor domain and inspect reports or verification pages on an outside provider domain without needing to log in.
- Treat the outside provider route as the strongest part of the evidence, not the vendor marketing copy around it.
- Look for repeated product-level behavior across the catalog, not just one showcase example.
- Do not overread it as proof that every current lot is covered or current unless the linked report trail itself supports that.
This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.
PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.
Medvinci Research is currently one of the strongest curated cases on the site because readers can inspect a repeatable public evidence trail without logging in.
Readers can leave the vendor marketing layer and inspect verification publicly.
This is the strongest public pattern because the verification step routes into an outside provider layer.
Current review touched 17 products and 23 document/link destinations.
2 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.
Score 7.8 from pb evidence score.
PB Curated Assessment: Strong. This is our own trust/transparency rubric and is kept separate from the PB score.
Under the formula retired on Aug 28, 2026 this vendor scores 7.97 — the live evidence-first score is 8.68 (+0.71). What changed and why: scoring methodology.
Observed from public domain records and the vendor's own site on Aug 27, 2026. Identity facts are shown for context and do not affect scores.
Assayed content is not fill accuracy. Laboratories report net peptide content, and peptides ship as salts, so an honestly filled vial commonly assays below its gross label — a figure under 100% is not evidence of a short vial. These numbers are also not comparable between vendors: they exist only where a laboratory reports net content, so they partly reflect which laboratory a vendor uses.
Holding a certificate for this vendor that is not here? Send it to the archive →
Same third-party review signals shown on the vendor board. Historical Trustpilot records are retained for reference and are not linked as active profiles.
PB score is the number you should read first on this page. It starts with trust evidence, pricing coverage, and third-party review signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available. Reviewed transparency evidence contributes a bounded amount — shown as a trust lift for source-benchmarked vendors, and folded into the base score for PB-evidence vendors.
This vendor’s score is evidence-first: verifiable testing evidence forms the backbone, and outside review sources are a bounded adjustment that can warn far more than it can boost. The terms below sum to the displayed score (small rounding aside). Full formula on the scoring methodology page.
WHAT THIS PAGE IS
- Board-ranked vendor profile with source-linked benchmark inputs
- No Finnrick score currently linked
- No Peptide Critic score currently linked
- Includes historical Trustpilot review coverage (vendor no longer listed on Trustpilot)
- No Pep Review Pro profile currently linked
CURRENT LIMITS
- Not an original lab test or editorial review
- Source scales and methodologies differ across sites
- Depends on source site freshness and formatting
These are representative public examples from the vendor testing review queue. They show how product pages in the catalog expose public report or verification paths, but they should still be read as examples rather than proof for every current lot.
In other words: the relationship registry above captures the vendor-to-provider link itself, while the examples below show what that link looks like across real product pages.
METHODOLOGY
How to read this benchmark
This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.
A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.
Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.